RZ-520
Immune & Inflammatory Disease
PreclinicalActive
Key Facts
About Rezubio
Rezubio develops gut-restricted drugs using its Membrane-Anchored Drug Design platform to create safer, more effective treatments for metabolic and inflammatory diseases.
View full company profile